학술논문

Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL)
Document Type
article
Source
Hematological Oncology. 41(S2)
Subject
Biomedical and Clinical Sciences
Cardiovascular Medicine and Haematology
Oncology and Carcinogenesis
Cardiorespiratory Medicine and Haematology
Immunology
Cardiovascular medicine and haematology
Language